CVE:VRS - Verisante Technology Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeC$0.02 - C$0.0252-Week RangeC$0.01 - C$0.06VolumeN/AAverage Volume256,747 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Verisante Technology Inc., a medical device company, engages in commercializing skin cancer detection systems. The company's products comprise Verisante Aura, which helps in the detection of various forms of skin cancer, including basal cell and squamous cell carcinoma, and melanoma; and Verisante Core for the detection of lung, cervical, gastrointestinal, and colo-rectal cancers. It also owns all the rights to the ClearVu and ClearVu Elite endoscopy systems for the detection of lung cancer. Verisante Technology has a licensing agreement with the BC Cancer Agency for the manufacture, distribution, and sale of products based on patented skin cancer detection technology. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was founded in 2006 and is based in Richmond, Canada. Receive VRS News and Ratings via Email Sign-up to receive the latest news and ratings for VRS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange CVE Industry Medical Appliances & Equipment Sub-IndustryN/A SectorMedical Current SymbolCVE:VRS Previous Symbol CUSIPN/A Webwww.verisante.com Phone+1-604-6050507Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A OptionableOptionable Verisante Technology (CVE:VRS) Frequently Asked Questions What is Verisante Technology's stock symbol? Verisante Technology trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VRS." Has Verisante Technology been receiving favorable news coverage? Press coverage about VRS stock has trended somewhat positive on Thursday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Verisante Technology earned a daily sentiment score of 1.7 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the stock's share price in the near term. Who are some of Verisante Technology's key competitors? Some companies that are related to Verisante Technology include Bioquell (BQE), Consort Medical (CSRT), Deltex Medical Group (DEMG), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), Intelligent Ultrasound Group (MED), LiDCO Group (LID), Lucid (LCDX) and Smith & Nephew (SN). Who are Verisante Technology's key executives? Verisante Technology's management team includes the folowing people: Mr. Thomas A. Braun BA, J.D., LLM, Chief Exec. Officer, Pres and Director (Age 50)Ms. Anna Trinh B.Comm LLB, Chief Financial Officer, Corp. Counsel and Sec. (Age 44)Mr. Rizah Bahic, Exec. Officer How do I buy shares of Verisante Technology? Shares of VRS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Verisante Technology's official website? The official website for Verisante Technology is http://www.verisante.com/. How can I contact Verisante Technology? Verisante Technology's mailing address is 2309 41st Ave W Suite 306, VANCOUVER, BC V6M 2A3, Canada. The company can be reached via phone at +1-604-6050507. MarketBeat Community Rating for Verisante Technology (CVE VRS)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 45 (Vote Outperform)Underperform Votes: 41 (Vote Underperform)Total Votes: 86MarketBeat's community ratings are surveys of what our community members think about Verisante Technology and other stocks. Vote "Outperform" if you believe VRS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/21/2019 by MarketBeat.com StaffFeatured Article: How do taxes affect a CDs total return?